本页面由Tiger Trade Technology Pte. Ltd.提供服务

诺和诺德

40.01
-7.4100-15.63%
成交量:7,285.08万
成交额:29.25亿
市值:1,776.07亿
市盈率:11.05
高:41.09
开:40.16
低:39.61
收:47.42
52周最高:93.80
52周最低:39.61
股本:44.39亿
流通股本:31.88亿
量比:13.41
换手率:2.29%
股息:1.72
股息率:4.30%
每股收益(TTM):3.62
每股收益(LYR):3.62
净资产收益率:60.70%
总资产收益率:17.43%
市净率:6.22
市盈率(LYR):11.05

数据加载中...

公司资料

公司名字:
诺和诺德
交易所:
NYSE
成立时间:
1923
员工人数:
69150
公司地址:
Novo Alle 1,Bagsvaerd,Capital Region of Denmark,Denmark
邮编:
2880
传真:
- -
简介:
Novo Nordisk A/S成立于1989年,由两家丹麦公司Nordisk Gentofte A/S和Novo Industri A/S合并而成。该公司是一家全球性的医疗保健公司,也是肥胖和糖尿病护理、制造和营销包括GLP-1受体激动剂和现代胰岛素在内的医药产品的世界领先企业。总部位于丹麦,业务遍及约80个国家,产品销往约170个国家。

董事

名称
职位
Helge Lund
Chair and Director
Henrik Poulsen
Vice Chair and Director

股东

名称
职位
Maziar Mike Doustdar
Chief Executive Officer and President
Elin Jäger
Senior Vice President, chief of staff to CEO; Corporate Strategy & Sustainability
Karsten Munk Knudsen
Chief Financial Officer and Executive Vice President
Camilla Sylvest
Executive Vice President, Commercial Strategy & Corporate Affairs
David Moore
Executive Vice President, US Operations
Emil Kongshøj Larsen
Executive Vice President, International Operations
Henrik Wulff
Executive Vice President, CMC & Product Supply
Hong Chow
Executive Vice President, Product & Portfolio Strategy
Jamey Millar
Executive Vice President, US Operations
John F. Kuckelman
Senior vice president, chief of staff to CEO; Corporate Strategy & Sustainability
Kasper Bødker Mejlvang
Executive Vice President, CMC & Product Supply
Lars Fruergaard Jørgensen
CEO and President
Ludovic Helfgott
Executive Vice President, Product & Portfolio Strategy
Marcus Schindler
CSO and Executive Vice President, Research & Early Development
Martin Holst Lange
Chief Scientific Officer and Executive Vice President, R&D
Tania Sabroe
Executive Vice President, People, Organisation & Corporate Affairs
Thilde Hummel Bøgebjerg
Executive Vice President, Enterprise IT and Quality